Literature DB >> 34965379

Persister cancer cells: Iron addiction and vulnerability to ferroptosis.

Raphaël Rodriguez1, Stuart L Schreiber2, Marcus Conrad3.   

Abstract

Ferroptosis is a unique type of non-apoptotic cell death resulting from the unrestrained occurrence of peroxidized phospholipids, which are subject to iron-mediated production of lethal oxygen radicals. This cell death modality has been detected across many organisms, including in mammals, where it can be used as a defense mechanism against pathogens or even harnessed by T cells to sensitize tumor cells toward effective killing. Conversely, ferroptosis is considered one of the main cell death mechanisms promoting degenerative diseases. Emerging evidence suggests that ferroptosis represents a vulnerability in certain cancers. Here, we critically review recent advances linking ferroptosis vulnerabilities of dedifferentiating and persister cancer cells to the dependency of these cells on iron, a potential Achilles heel for small-molecule intervention. We provide a perspective on the mechanisms reliant on iron that contribute to the persister cancer cell state and how this dependency may be exploited for therapeutic benefits.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34965379      PMCID: PMC9152905          DOI: 10.1016/j.molcel.2021.12.001

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   19.328


  52 in total

1.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.

Authors:  David L Schonberg; Tyler E Miller; Qiulian Wu; William A Flavahan; Nupur K Das; James S Hale; Christopher G Hubert; Stephen C Mack; Awad M Jarrar; Robert T Karl; Ann Mari Rosager; Anne M Nixon; Paul J Tesar; Petra Hamerlik; Bjarne W Kristensen; Craig Horbinski; James R Connor; Paul L Fox; Justin D Lathia; Jeremy N Rich
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

Review 2.  Mechanisms of mammalian iron homeostasis.

Authors:  Kostas Pantopoulos; Suheel Kumar Porwal; Alan Tartakoff; L Devireddy
Journal:  Biochemistry       Date:  2012-07-09       Impact factor: 3.162

Review 3.  Non-genetic mechanisms of therapeutic resistance in cancer.

Authors:  Jean-Christophe Marine; Sarah-Jane Dawson; Mark A Dawson
Journal:  Nat Rev Cancer       Date:  2020-10-08       Impact factor: 60.716

Review 4.  Recent progress in nanotechnology based ferroptotic therapies for clinical applications.

Authors:  Yingying Xu; Zhuo Qin; Jing Ma; Weiling Cao; Peng Zhang
Journal:  Eur J Pharmacol       Date:  2020-05-27       Impact factor: 4.432

5.  Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model.

Authors:  Yan Zhang; Hui Tan; Jacob D Daniels; Fereshteh Zandkarimi; Hengrui Liu; Lewis M Brown; Koji Uchida; Owen A O'Connor; Brent R Stockwell
Journal:  Cell Chem Biol       Date:  2019-02-21       Impact factor: 8.116

6.  Iron and copper in mitochondrial diseases.

Authors:  Wenjing Xu; Tomasa Barrientos; Nancy C Andrews
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

Review 7.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

8.  Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers.

Authors:  Ross A Weber; Omkar Zilka; Mariluz Soula; Hanan Alwaseem; Konnor La; Frederick Yen; Henrik Molina; Javier Garcia-Bermudez; Derek A Pratt; Kıvanç Birsoy
Journal:  Nat Chem Biol       Date:  2020-08-10       Impact factor: 15.040

9.  Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury.

Authors:  Wulf Tonnus; Claudia Meyer; Christian Steinebach; Alexia Belavgeni; Anne von Mässenhausen; Nadia Zamora Gonzalez; Francesca Maremonti; Florian Gembardt; Nina Himmerkus; Markus Latk; Sophie Locke; Julian Marschner; Wenjun Li; Spencer Short; Sebastian Doll; Irina Ingold; Bettina Proneth; Christoph Daniel; Nazanin Kabgani; Rafael Kramann; Stephen Motika; Paul J Hergenrother; Stefan R Bornstein; Christian Hugo; Jan Ulrich Becker; Kerstin Amann; Hans-Joachim Anders; Daniel Kreisel; Derek Pratt; Michael Gütschow; Marcus Conrad; Andreas Linkermann
Journal:  Nat Commun       Date:  2021-07-20       Impact factor: 14.919

10.  CD44 regulates epigenetic plasticity by mediating iron endocytosis.

Authors:  Sebastian Müller; Fabien Sindikubwabo; Tatiana Cañeque; Anne Lafon; Antoine Versini; Bérangère Lombard; Damarys Loew; Ting-Di Wu; Christophe Ginestier; Emmanuelle Charafe-Jauffret; Adeline Durand; Céline Vallot; Sylvain Baulande; Nicolas Servant; Raphaël Rodriguez
Journal:  Nat Chem       Date:  2020-08-03       Impact factor: 24.427

View more
  9 in total

1.  Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer.

Authors:  Johanna M Buschhaus; Shrila Rajendran; Brock A Humphries; Alyssa C Cutter; Ayşe J Muñiz; Nicholas G Ciavattone; Alexander M Buschhaus; Tatiana Cañeque; Zeribe C Nwosu; Debashis Sahoo; Avinash S Bevoor; Yatrik M Shah; Costas A Lyssiotis; Pradipta Ghosh; Max S Wicha; Raphaël Rodriguez; Gary D Luker
Journal:  Oncogene       Date:  2022-06-22       Impact factor: 8.756

2.  Novel Iron Oxide Nanoparticles Induce Ferroptosis in a Panel of Cancer Cell Lines.

Authors:  Roberto Fernández-Acosta; Claudia Iriarte-Mesa; Daniel Alvarez-Alminaque; Behrouz Hassannia; Bartosz Wiernicki; Alicia M Díaz-García; Peter Vandenabeele; Tom Vanden Berghe; Gilberto L Pardo Andreu
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

Review 3.  Ferroptosis and Autoimmune Diseases.

Authors:  Benjamin Lai; Chien-Hsiang Wu; Chao-Yi Wu; Shue-Fen Luo; Jenn-Haung Lai
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

Review 4.  Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance.

Authors:  Jingjing Deng; Mei Zhou; Tingting Liao; Wenlong Kuang; Hui Xia; Zhengrong Yin; Qi Tan; Yumei Li; Siwei Song; E Zhou; Yang Jin
Journal:  Front Cell Dev Biol       Date:  2022-03-24

5.  Long noncoding RNA LINC01606 protects colon cancer cells from ferroptotic cell death and promotes stemness by SCD1-Wnt/β-catenin-TFE3 feedback loop signalling.

Authors:  Yajun Luo; Siqi Huang; Jinlai Wei; He Zhou; Wuyi Wang; Jianguo Yang; Qican Deng; Hao Wang; Zhongxue Fu
Journal:  Clin Transl Med       Date:  2022-04

Review 6.  Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer.

Authors:  Chunmei Zhang; Ning Liu
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

Review 7.  Pharmacological targets for the induction of ferroptosis: Focus on Neuroblastoma and Glioblastoma.

Authors:  Luciano Ferrada; María José Barahona; Katterine Salazar; Alejandro S Godoy; Matias Vera; Francisco Nualart
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

8.  A non-canonical vitamin K cycle is a potent ferroptosis suppressor.

Authors:  Eikan Mishima; Junya Ito; Zijun Wu; Toshitaka Nakamura; Adam Wahida; Sebastian Doll; Wulf Tonnus; Palina Nepachalovich; Elke Eggenhofer; Maceler Aldrovandi; Bernhard Henkelmann; Ken-Ichi Yamada; Jonas Wanninger; Omkar Zilka; Emiko Sato; Regina Feederle; Daniela Hass; Adriano Maida; André Santos Dias Mourão; Andreas Linkermann; Edward K Geissler; Kiyotaka Nakagawa; Takaaki Abe; Maria Fedorova; Bettina Proneth; Derek A Pratt; Marcus Conrad
Journal:  Nature       Date:  2022-08-03       Impact factor: 69.504

9.  Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells.

Authors:  Shangwen Jing; Yantong Lu; Jing Zhang; Yan Ren; Yousheng Mo; Dongdong Liu; Lining Duan; Zhongyu Yuan; Changjun Wang; Qi Wang
Journal:  Drug Des Devel Ther       Date:  2022-09-07       Impact factor: 4.319

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.